Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN4A | P35499 | 9/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | SCN1A | P35498 | 2/20 | 0.48 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.48 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.48 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.48 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.48 |
| ▸ | GBA1 | P04062 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.48 |
| ▸ | HTR2B | P41595 | 1/20 | 0.48 |
| ▸ | SCN7A | Q01118 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16606241 | 0.86 | SCN4A (0.42) | SCN4ACYP1A2LMNASCN1ASCN5A | |
| SCHEMBL16572835 | 0.84 | KDM4E (0.45) | SCN4ACYP1A2LMNASCN1ASCN5A | |
| SCHEMBL12440951 | 0.84 | ALDH1A1 (0.44) | SCN4ACYP1A2LMNASCN1ASCN5A | |
| SCHEMBL9945947 | 0.84 | LMNA (0.41) | SCN4ACYP1A2LMNASCN1ASCN5A | |
| SCHEMBL14409292 | 0.84 | ACHE (0.44) | SCN4ACYP1A2LMNASCN1ASCN5A | |
| SCHEMBL15183452 | 0.84 | TRPA1 (0.46) | SCN4ACYP1A2LMNASCN1ASCN5A | |
| SCHEMBL29581599 | 0.83 | SCN4A (0.37) | SCN4ACYP1A2LMNASCN1ASCN5A | |
| SCHEMBL27387343 | 0.83 | SCN4A (0.37) | SCN4ACYP1A2LMNASCN1ASCN5A | |
| SCHEMBL3718003 | 0.83 | SCN4A (0.44) | SCN4ACYP1A2LMNASCN1ASCN5A | |
| SCHEMBL25742996 | 0.82 | SCN4A (0.37) | SCN4ACYP1A2LMNASCN1ASCN5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240026053-A1 | TRANSPARENT ARTICLE | POLYPLASTICS CO., LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| US-11877506-B2 | Polycyclic aromatic compound | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2024-01-16 | — | — | US | disclosed |
| US-20210340320-A1 | Oligomer (2,6-dimethylphenylene ether) Together with Fabrication Method and Cured Product Thereof | CPC CORPORATION, TAIWAN (TW) | 2021-11-04 | — | — | US | disclosed |
| CN-112074506-A | 4' -halo-containing nucleotide and nucleoside therapeutic compositions and uses related thereto | 埃默里大学 | 2020-12-11 | — | — | CN | disclosed |
| EP-3359585-B1 | USE OF COMPOUNDS IN POLYMERISATION REACTIONS | SCG CHEMICALS CO LTD (TH) | 2019-07-24 | — | — | EP | disclosed |
| US-20170196862-A2 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2017-07-13 | — | — | US | disclosed |
| CN-104334525-B | catechol O-methyltransferase activity inhibiting compounds | 奥赖恩公司 | 2017-05-10 | — | — | CN | disclosed |
| WO-2017060691-A1 | USE OF COMPOUNDS IN POLYMERISATION REACTIONS | SCG CHEMICALS CO., LTD. (TH) | 2017-04-13 | — | — | WO | disclosed |
| US-9365588-B2 | Benzoxazines as modulators of ion channels | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2016-06-14 | — | — | US | disclosed |
| CN-104334525-A | Catechol o-methyltransferase activity inhibiting compounds | ORION CORP | 2015-02-04 | — | — | CN | disclosed |
| US-20090184631-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-07-23 | — | — | US | disclosed |
| US-20090179555-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-07-16 | — | — | US | disclosed |
| US-20090179555-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-07-16 | — | — | US | disclosed |
| US-20090174316-A1 | Novel red electroluminescent compounds and organi electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-07-09 | — | — | US | disclosed |
| US-20090174316-A1 | Novel red electroluminescent compounds and organi electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-07-09 | — | — | US | disclosed |
| US-20090165860-A1 | Electroluminescent device using electroluminescent compounds | GRACEL DISPLAY INC. (KR) | 2009-07-02 | — | — | US | disclosed |
| US-20090159130-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-06-25 | — | — | US | disclosed |
| US-20090153037-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-06-18 | — | — | US | disclosed |
| US-20090145483-A1 | Novel electroluminescent compounds and organic electroluminescent device suing the same | GRACEL DISPLAY INC. (KR) | 2009-06-11 | — | — | US | disclosed |
| US-20090078317-A1 | Organometalic compounds for electroluminescence and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11877506-B2 | Polycyclic aromatic compound | F11, C1R, RNF31 | SCN4A 2579/4885CYP1A2 133/4885LMNA 692/4885 |
| US-20090145483-A1 | Novel electroluminescent compounds and organic electroluminescent device suing the same | LEF1, ODC1, AOC2 | SCN4A 3046/4885CYP1A2 1920/4885LMNA 3749/4885 |
| US-20090078317-A1 | Organometalic compounds for electroluminescence and organic electroluminescent device using the same | OCIAD1, L1CAM, OCIAD2 | SCN4A 2870/4885CYP1A2 1002/4885LMNA 1976/4885 |
| US-20090184631-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | ALDH1A2, ODC1, NDUFS2 | SCN4A 2157/4885CYP1A2 697/4885LMNA 3971/4885 |
| US-20090174316-A1 | Novel red electroluminescent compounds and organi electroluminescent device using the same | ALPI, IK, ALDH1A2 | SCN4A 3331/4885CYP1A2 2596/4885LMNA 4437/4885 |
| US-20090153037-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | NDUFS2, ALDH1A2, ODC1 | SCN4A 2225/4885CYP1A2 723/4885LMNA 3962/4885 |
| US-20090159130-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | AOX1, LEF1, ODC1 | SCN4A 2210/4885CYP1A2 750/4885LMNA 4071/4885 |
| US-20090179555-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | NDUFS2, ALDH1A2, ODC1 | SCN4A 2225/4885CYP1A2 723/4885LMNA 3962/4885 |
| US-20170196862-A2 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | CFTR, SCNN1B, SLC26A4 | SCN4A 79/4885CYP1A2 3773/4885LMNA 3018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.